Welcome to the e-CCO Library!

P598: The utility of the “Low Anterior Resection Syndrome SCORE” in assessing the postoperative outcomes of patients undergoing restorative proctocolectomy with ileal pouch anal-anastomosis for Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Perotti, S.(1)*;Mineccia, M.(1);Daperno, M.(2);Massucco, P.(1);Gonella, F.(1);Ferrero , A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P599 Trimester exposure and pregnancy outcomes in women exposed to golimumab: Results from the company pharmacovigilance database
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Esslinger1, M. Otero-Lobato1, S. Gabriel2, M. Clark3, P. Sheridan2, A. Geldhof1

Created: Thursday, 30 January 2020, 10:12 AM
P599: Azathioprine in the prevention of anti-infliximab antibody formation: A pilot dose-finding study
Year: 2022
Source: ECCO'22
Authors: Kojecký, V.(1,2);Wasserbauer , M.(3);Keil, R.(3);
Created: Friday, 11 February 2022, 3:56 PM
P599: Development of an inflammatory bowel disease-specific nutrition screening tool (IBD-NST)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Wall*1, B. Wilson1, J. Sanderson2, M. Lomer1,3

Created: Friday, 22 February 2019, 9:41 AM
P599: Home testing for faecal calprotectin: follow-up results from the first UK trial
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Raker J., Ford C., Pavlidis P., Medcalf L., Choong L.M., Chung-Faye G., Dubois P., Hayee B.

Created: Wednesday, 20 February 2019, 10:36 AM
P599: Perspectives on disease- and treatment-related issues encountered by patients with Inflammatory Bowel Disease: a qualitative concept mapping study
Year: 2021
Source: ECCO'21 Virtual
Authors: Risager Christensen, K.(1);Steenholdt, C.(1);Skougaard, M.(2);Ainsworth, M.A.(3);Brynskov, J.(1);Buhl, S.(1);Kristensen, L.E.(2);Schjødt Jørgensen, T.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P599: Short- and long-term outcome of minimally invasive approach for Crohn’s disease: Comparison between single incision, robotic-assisted and conventional laparoscopy
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Zambonin1*, F. Giudici1, F. Ficari1, F. Rogai2, S. Scaringi3

Created: Thursday, 21 February 2019, 9:14 AM
P600 Vedolizumab dose optimisation: Findings from a Belgian registry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Louis1, V. Muls2, P. Bossuyt3, A. Colard4, A. Nakad5, D. Baert6, F. Mana7, P. Caenepeel8, S. Vanden Branden9, S. Vermeire10, F. D’Heygere11, B. Strubbe12, A. Cremer13, J.C. Coche14, V. Setakhr15, F. Baert16, A. Vijverman17, J.L. Coenegrachts18, F. Flamme19, A. Hantson20, K. Wijnen20, E. Piters20, G. Hantsbarger21, P. Dolin22

Created: Thursday, 30 January 2020, 10:12 AM
P600: Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

V. Caneparo1,2, B. Verstockt3,4, S. Vermeire3,4, S. Landolfo1, M. Gariglio2, M. De Andrea1,2*

Created: Thursday, 21 February 2019, 9:14 AM
P600: Democratic deliberation to assess Veteran preferences for biosimilar medication switching for the treatment of Inflammatory Bowel Disease in a resource-conscious setting.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ryan, K.(1);Hou, J.K.(2,3)*;Baker, J.(4);Krenz, C.(1);De Vries, R.(1);Waljee, A.K.(4,5);
Created: Friday, 14 July 2023, 11:05 AM
P600: Infliximab trough levels for remission induction and long term therapy management of inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Perdigoto D., Portela F., Ferreira M., Mendes S., Freire P., Ferreira M., Lopes S., Tomé L.

Created: Wednesday, 20 February 2019, 10:36 AM
P600: Real-world clinical characteristics and therapeutic strategies in patients with moderate-to-severe Inflammatory Bowel Disease in Argentina: Data from the RISE AR study
Year: 2021
Source: ECCO'21 Virtual
Authors: Lasa, J.S.(1,2);Sambuelli, A.(3);Zubiaurre, I.(2);Correa, G.J.(4);Lubrano, P.(5);Balderramo, D.C.(6,7);Ruffinengo, O.(8);Brion, L.(9);Leonardi, D.B.(9);El-Hakeh, J.(9);Guimaraens, P.N.(9);Olivera Sendra, P.(1,5);
Created: Wednesday, 2 June 2021, 4:12 PM
P600: Serologic response to COVID-19 vaccines in IBD patients: a prospective study
Year: 2022
Source: ECCO'22
Authors: Martin ArranzPhD- MD, M.D.(1);García Ramírez, L.(2);Montero Vega, D.(3);Martín-Arraz, E.(2);Sánchez Azofra, M.(2);Poza Cordon, J.(2);Rueda Garcia, J.L.(2);Noci Belda, J.(2);Verges Martínez-Meco, T.(2);Blanco San Miguel, P.(2);Suarez Ferrer, C.(2);
Created: Friday, 11 February 2022, 3:56 PM
P600: Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study from Finland
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Eberl*1, T. Hallinen2, C-G. af Björkesten3, M. Heikkinen4, E. Hirsi5, M. Kellokumpu6, I. Koskinen7, V. Moilanen8, C. Nielsen9, H. Nuutinen10, U-M. Suhonen11, K. Utriainen12, I. Vihriälä13, E. Soini2, C. Wennerström14, R. Nissinen15, A. Borsi16, M. Koivunen15, J. Tillonen17, T. Sipponen1

Created: Friday, 22 February 2019, 9:41 AM
P601 Development and validation of dried blood spot sampling as a tool to identify the best time point to measure predictive ustekinumab serum concentrations in patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Van den Berghe1, B. Verstockt2,3, E. Vandeput2, V. Ballet2, A. Gils1, M. Ferrante2,3, S. Vermeire2,3, D. Thomas1

Created: Thursday, 30 January 2020, 10:12 AM
P601: Are Inflammatory Bowel Disease patients’ expectations met by dietetic services?
Year: 2021
Source: ECCO'21 Virtual
Authors: McCarthy, N.(1);Schultz, M.(2);Wall, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P601: Can Amitriptylin improve the quality of life in patients with Crohn's disease?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Jigaranu A.O., Dranga M., Gavrilescu O., Popa I., Ungureanu I., Mihai C., Cijevschi-Prelipcean C.

Created: Wednesday, 20 February 2019, 10:36 AM
P601: Differential cytokine profiles and drop of faecal calprotectin for prediction of primary response to infliximab induction therapy in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Mateos1, E. Sáez1,2, I. Moret1,3, D. Hervás4, L. Tortosa1,3, E. Cerrillo2,3, M. Iborra2,3, M. García2, P. Nos1,2,3, B. Beltrán1,2,3

Created: Friday, 22 February 2019, 9:41 AM
P601: Pneumococcal vaccination in patients with immunomediated inflammatory diseases (IMIDs) using a real-world multidisciplinary project
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Martins, A.(1);Silva, F.(2);Canelas, G.(2);Ribeiro, L.(3);Pinto, S.(3);Sarmento, A.(3);Magro, F.(4);Ferreira de Abreu, C.M.(5)*;
Created: Friday, 14 July 2023, 11:05 AM